Italy Bioinformatics Market Analysis Report [2022-30] I Insights10

Italy Bioinformatics Market Analysis

$ 3999

The Italy Bioinformatics market is projected to grow from $368.4 Mn in 2022 to $1,191.21 Mn by 2030, registering a CAGR of 15.8% during the forecast period of 2022 - 2030. The main factors driving the growth would be a strong industry presence and government initiatives and support. The market is segmented by technology and by application. Some of the major players include Next Genomics (ITA), Genomia (ITA), EnGenome (ITA), ThermoFisher Scientific, IBM Life Sciences, and Agilent Technologies.

ID: IN10ITHS001 CATEGORY: Healthcare Services GEOGRAPHY: Italy AUTHOR: Neha Davda

Buy Now

Italy Bioinformatics Market Executive Summary

The Italy Bioinformatics market is projected to grow from $368.4 Mn in 2022 to $1,191.21 Mn by 2030, registering a CAGR of 15.8% during the forecast period of 2022 - 2030. In 2019, healthcare spending in Italy was 8.67% of its GDP or $2,906 per capita. Both in terms of per capita spending and as a percentage of GDP in 2019, health spending was far behind the average for the EU. In 2019, about 74% of health spending was publicly supported, which is less than the average for the EU of 80%.

An interdisciplinary area of biology and information technology is the field of bioinformatics. Data generation, data warehousing, data mining, data management, and other techniques are used in bioinformatics. Bioinformatics software and tools are used as integrated solutions to provide statistical methods and data processing algorithms for applications including next-generation sequencing, modeling of genomic and proteomic structure, and three-dimensional drug discovery. Europe is the second largest leader in the bioinformatics market and Italy's bioinformatics market is a rapidly growing industry.

italy bioinformatics market analysis

Market Dynamics

Market Growth Drivers

The bioinformatics market in Italy is marked by a strong presence of SMEs and a growing number of research institutes and universities which can boost the market. Moreover, the usage of bioinformatics in healthcare is anticipated to increase over the next several years as the Italian government pushes for further digitalization of healthcare services. This covers the application of bioinformatics to population health management and the detection and treatment of diseases. The European Molecular Biology Network (EMBnet), a European initiative also spreads bioinformatics knowledge through a local infrastructure and local training courses to boost the market.

Market Restraints

In Italy, bioinformatics is not as widely adopted and used as in some other nations and it is still necessary to raise awareness of the advantages and prospects of bioinformatics among healthcare professionals, researchers, and the general public. Further, the lack of skilled professionals in the field of bioinformatics limits the growth of the market.

Competitive Landscape

Key Players

Next Genomics (ITA)
Genomia (ITA)
EnGenome (ITA)
ThermoFisher Scientific
IBM Life Sciences
Agilent Technologies

Notable Recent Deals

October 2022: ThermoFisher Scientific announced the acquisition of The Binding Site Group, a global leader in specialty diagnostics, for a value of $2.8 Bn. With this acquisition, ThermoFisher Scientific is to expand the specialty diagnostics segment with a market leader in oncology testing for multiple myeloma detection and monitoring.

Healthcare Policies and Regulatory Landscape

Several governmental organizations and institutes, notably the Ministry of Health, the Italian Medicines Agency (AIFA), and the Italian National Institute of Health, regulate the healthcare policies and regulatory environment for the Italian bioinformatics market (ISS). The General Data Protection Regulation (GDPR), governs the collection, storage, and use of personal data, including health data, is applicable to all businesses with operations in the EU. Additionally, the Italian Data Protection Authority (IDPA) is responsible for regulating the processing of genetic data in Italy.

Reimbursement Scenario

The National Health Service (Servizio Sanitario Nazionale, SSN), which is in charge of providing and funding healthcare services for Italian citizens, is primarily responsible for determining the reimbursement policies for the bioinformatics market in Italy. The SSN is funded by a combination of taxes and patient contributions and is run by the Ministry of Health. The SSN establishes reimbursement guidelines through a procedure known as listing. Clinical effectiveness, financial impact, and cost-effectiveness are taken into account while evaluating products. Further, policies for bioinformatics product reimbursement also rely on the product's kind and intended usage. Products used for therapeutic reasons may not be reimbursed the same way as those used for diagnostic purposes.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Bioinformatics Market Segmentation

By Technology (Revenue, USD Billion):

Knowledge Management Tools
Bioinformatics Platforms
Bioinformatics Services

By Application (Revenue, USD Billion):

Metabolomics
Molecular phylogenetics
Transcriptomics
Chemoinformatic & drug design
Genomics
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.